Vertex Pharmaceuticals (VRTX) Q3 Earnings and …

VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View RaisedVertex (VRTX) Q3 Earnings Beat, Sales Miss, Raises '23 View - Yahoo FinanceVertex: Q3 Earnings Snapshot - Yahoo Finance

88%
OFF

Vertex Pharmaceuticals Tops Q3 Estimates | The Motley Fool

2 weeks from now

Nov 4, 2024 · Non-GAAP earnings per share of $4.38 beat analyst estimates of $4.08. ... Vertex Pharmaceuticals (VRTX-1.88%), a leader in cystic fibrosis treatments, released its third …

fool.com

$4.38
OFF

Vertex Pharmaceuticals (VRTX) Q3 Earnings And Revenues Top …

2 weeks from now

Nov 4, 2024 · Vertex Pharmaceuticals (VRTX Quick Quote VRTX - Free Report) came out with quarterly earnings of $4.38 per share, beating the Zacks Consensus Estimate of $4.13 per …

zacks.com

$4.38
OFF

VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View Raised

2 weeks from now

Nov 5, 2024 · Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $4.38 per share for the third quarter of 2024, surpassing the Zacks Consensus Estimate of $4.13. In …

yahoo.com

05%
OFF

Vertex Pharmaceuticals Q3 Earnings Beat Estimates - VRTX

2 weeks from now

Vertex Pharmaceuticals (VRTX) reported Q3 earnings of $4.38 per share, surpassing the Zacks Consensus Estimate of $4.13 and reflecting a 6.05% earnings surprise. Revenues for the …

investingsnacks.com

$4.38
OFF

Vertex Pharmaceuticals (VRTX) Q3 Earnings And Revenues Top …

2 weeks from now

Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $4.38 per share, beating the Zacks Consensus Estimate of $4.13 per share. This compares to earnings of $4.08 per share …

msn.com

$3.97
OFF

Vertex (VRTX) Q3 Earnings Beat, Sales Miss, Raises '23 View

2 weeks from now

Nov 7, 2023 · Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings per share (EPS) of $3.97 in third-quarter 2023, beating the Zacks Consensus Estimate of $3.92.The …

yahoo.com

$852
OFF

Vertex Pharmaceuticals Inc. Q3 Adjusted Earnings Beat Estimates

2 weeks from now

Nov 2, 2021 · (RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) revealed a profit for its third quarter that climbed from last year. The company's earnings totaled $852 million, or $3.28 per …

nasdaq.com

$2.77
OFF

Vertex (VRTX) Q3 Earnings: Taking A Look At Key Metrics Versus …

2 weeks from now

Nov 5, 2024 · Vertex Pharmaceuticals (VRTX Quick Quote VRTX - Free Report) reported $2.77 billion in revenue for the quarter ended September 2024, representing a year-over-year …

zacks.com

$3.56
OFF

Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings And Revenue …

2 weeks from now

Nov 2, 2021 · Vertex Pharmaceuticals (VRTX) came out with quarterly earnings of $3.56 per share, beating the Zacks Consensus Estimate of $3.12 per share. This compares to earnings …

nasdaq.com

6%
OFF

Vertex Pharmaceuticals (VRTX) Earnings Date And Reports 2025

2 weeks from now

Vertex Pharmaceuticals announced Q3 2024 earnings on November 4, 2024, reporting an EPS of $4.38, which topped the consensus estimate of $3.61 by $0.77. Quarterly revenue rose 11.6% …

marketbeat.com

$4.38
OFF

VRTX Q3 Earnings & Sales Trump Estimates, '24 Sales View Raised

2 weeks from now

Nov 5, 2024 · Vertex Pharmaceuticals Incorporated (VRTX Quick Quote VRTX - Free Report) reported adjusted earnings of $4.38 per share for the third quarter of 2024, surpassing the …

zacks.com

2%
OFF

Vertex (VRTX) Q3 Earnings On The Horizon: Analysts' Insights

2 weeks from now

Oct 30, 2024 · In its upcoming report, Vertex Pharmaceuticals (VRTX) is predicted by Wall Street analysts to post quarterly earnings of $4.13 per share, reflecting an increase of 1.2% …

nasdaq.com

$1.05
OFF

Vertex: Q3 Earnings Snapshot - Yahoo Finance

2 weeks from now

Nov 4, 2024 · BOSTON (AP) — Vertex Pharmaceuticals Inc. VRTX) on Monday reported third-quarter net income of $1.05 billion. On a per-share basis, the Boston-based company said it …

yahoo.com

$2.68
OFF

Vertex Pharmaceuticals Eyes Q3 Earnings Beat - VRTX

2 weeks from now

Nov 1, 2024 · Vertex Pharmaceuticals (VRTX) is expected to exceed expectations for Q3 2024 earnings, set to be reported on Nov. 4. The Zacks Consensus Estimate for revenues is $2.68 …

investingsnacks.com

$4.38
OFF

CCM Investment Advisers LLC Reduces Stock Holdings In Vertex ...

2 weeks from now

2 days ago · Vertex Pharmaceuticals (NASDAQ:VRTX - Get Free Report) last posted its earnings results on Monday, November 4th. The pharmaceutical company reported $4.38 earnings per …

marketbeat.com

9%
OFF

Vertex Pharmaceuticals Earnings Preview: What To Expect

2 weeks from now

2 days ago · VRTX reported an adjusted EPS of $4.04 in the most recent quarter, missing the consensus estimates by 11.9%. Vertex Pharmaceuticals exceeded earnings expectations in …

nasdaq.com

$4.08
OFF

Vertex Pharmaceuticals (VRTX) Tops Q3 Earnings Estimates

2 weeks from now

Nov 6, 2023 · Vertex Pharmaceuticals (VRTX Quick Quote VRTX - Free Report) came out with quarterly earnings of $4.08 per share, beating the Zacks Consensus Estimate of $3.92 per …

zacks.com

$3.41
OFF

Vertex Pharmaceuticals Earnings Preview: What To Expect - Inkl

2 weeks from now

3 days ago · The company is set to release its Q4 earnings on Wednesday, Feb. 3. Ahead of the event, analysts expect Vertex to report a profit of $3.41 per share on a diluted basis, down …

inkl.com

7%
OFF

Vertex Pharmaceuticals Earnings Preview: What To Expect - MSN

2 weeks from now

However, shares rose 5.7% following its strong Q3 earnings release on Nov. 4. The company reported revenue of $2.77 billion, up 11.7% year-over-year , exceeding Wall Street estimates …

msn.com

FAQs about Vertex Pharmaceuticals (VRTX) Q3 Earnings and … Coupon?

How did Vertex Pharmaceuticals Incorporated (VRTX) perform in Q3 2024?

Vertex Pharmaceuticals Incorporated VRTX reported adjusted earnings of $4.38 per share for the third quarter of 2024, surpassing the Zacks Consensus Estimate of $4.13. In the year-ago quarter, the company had recorded adjusted earnings of $4.08 per share. Earnings grew year over year owing to increased product revenues. ...

How much did Vertex Pharmaceuticals make in the third quarter?

The company's bottom line came in at $1.045 billion, or $4.01 per share. This compares with $1.035 billion, or $3.97 per share, in last year's third quarter. Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.143 billion or $4.38 per share for the period. ...

When is vertex releasing Q4 earnings?

The company is set to release its Q4 earnings on Wednesday, Feb. 3. Ahead of the event, analysts expect Vertex to report a profit of $3.41 per share on a diluted basis, down 4.5% from $3.57 per share in the year-ago quarter. The company beat the consensus estimates in two of the last four quarters while missing on two other occasions. ...

When is Vertex Pharmaceuticals' next earnings release date?

Vertex Pharmaceuticals has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 6th, 2024 based off last year's report dates. Learn more on VRTX's earnings history. Did Vertex Pharmaceuticals beat their earnings estimates last quarter? ...

How much do analysts expect from Vertex Pharmaceuticals?

The average estimate of 13 analysts surveyed by Zacks Investment Research was for earnings of $4.13 per share. The drugmaker posted revenue of $2.77 billion in the period, which also beat Street forecasts. Eleven analysts surveyed by Zacks expected $2.67 billion. Vertex expects full-year revenue in the range of $10.8 billion to $10.9 billion. ...

What is the consensus EPS estimate for vertex (VRTX)?

The current consensus EPS estimate is $4.19 on $2.72 billion in revenues for the coming quarter and $0.13 on $10.73 billion in revenues for the current fiscal year. Vertex (VRTX) delivered earnings and revenue surprises of 6.05% and 3.62%, respectively, for the quarter ended September 2024. ...